Post-exposure prophylaxis with SA58 (anti-SARS-COV-2 monoclonal antibody) nasal spray for the prevention of symptomatic COVID-19 in healthy adult workers: a randomized, single-blind, placebo-controlled clinical study
Song et al., Emerging Microbes & Infections, doi:10.1080/22221751.2023.2212806
https://c19early.org/song9.html